Morgan Stanley Upgrades Quantinuum to Overweight, Cuts Price Target
Morgan Stanley raised its rating on Quantinuum to Overweight from Equalweight but cut its price target from $78 to $62. Shares rose 3.42% in premarket trading.
Morgan Stanley raised its rating on Quantinuum to Overweight from Equalweight but cut its price target from $78 to $62. Shares rose 3.42% in premarket trading.